4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-056947
Principal Accounting Officer sold 236 shares at $7.76 ($1,831)
From the SEC's structured data for this filing
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-056947
Principal Accounting Officer sold 236 shares at $7.76 ($1,831)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…